Position in BBIO
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$598,312
+$234,219 QoQ
Shares Held
8,057
-4.4% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2023
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BBIO Over Time
Shares Held
Position Value (USD)
Derivatives in BBIO
reported options exposure · as of Jun 30, 2023CallValue
$244
CallShares
14,200
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026DRW Securities, LLC holds $16,479,491 across 58 Biotechnology names. BBIO ranks #7 (3.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PTCT |
Ptc Therapeutics, Inc.
|
18,169 | $1,237,853 | |
| 2 | KURA |
Kura Oncology, Inc.
|
132,174 | $1,074,574 | |
| 3 | ARGX |
Argenx SE
|
1,247 | $910,621 | |
| 4 | MNKD |
Mannkind Corp
|
305,121 | $747,546 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
12,426 | $701,944 | |
| 6 | INSM |
INSMED Inc
|
3,698 | $604,696 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
This page
|
8,057 | $598,312 | |
| 8 | XNCR |
Xencor Inc
|
48,442 | $584,210 |
All Filings in BBIO
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $598,312 | 8,057 | Shares | Other | 2026-05-13 | |
| 2025-06-30 | $364,093 | 8,432 | Shares | Other | 2025-08-14 | |
| 2023-06-30 | $244 | 14,200 | Call | Other | 2023-08-15 | |
| 2023-03-31 | $406 | 24,500 | Call | Other | 2023-05-15 | |
| No filing history on record for this holder in this stock. | ||||||